Reproductive health

Reproductive health

Empowering Patient Choices

BGI has been a pioneer in developing genomics based solutions across the reproductive health continuum.

Our market leading non-invasive prenatal test (NIPT), the NIFTY® test, was one of the first NIPTs on the market and has been trusted by over 1.5 million patients worldwide.

BGI also offers a wide range of other genetics tests including carrier screening, newborn screening for rare disease and PGS.

We continue to support and be involved in a wide range of research connected to maternal and child health, working with a wide range of partners across the world.

*Tests are subject to regional availability and not available in the USA.

Quick Contact